| Authors: |
Bratt O; Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; -Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden; cRegional Cancer Centre West, Gothenburg, Sweden. ola.bratt@gu.se., Andersson-Säll T; Regional Cancer Centre West, Gothenburg, Sweden., Arnsrud Godtman R; Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; -Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden., Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden., Gunnarsson O; Department of Urology, Ryhov County Hospital, Jönköping, Sweden., Lantz A; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden., Styrke J; Department of Diagnostics and Intervention, Urology and Andrology, Umeå University, Umeå, Sweden. |
